What belongs in a useful synthesis brief?
Provide sequence, terminal modifications, salt preference, quantity, intended laboratory use and analytical acceptance criteria. Discuss confidentiality and rights before disclosing proprietary information.
Make the molecular request unambiguous
A peptide synthesis brief should identify the exact amino-acid sequence, terminal groups, stereochemistry and any modifications or conjugations. Use a consistent notation and explain any nonstandard residues. Provide the intended laboratory application and the amount required for evaluation so that feasibility can be assessed against a real project rather than a product name alone.
The analytical requirements should follow the purpose. State how identity, purity and content will be assessed, and identify any additional attributes that could affect your experiment. If a counterion or salt form matters, include it explicitly. Define the requested packaging and any relevant handling constraints without assuming that all peptides share the same stability profile. This service is for sequence-defined research projects. It should not be used to invent a peptide identity for CBL-514, whose clinical program is described by its developer as a small-molecule formulation.
Connect the brief to the sample decision
Explain what a successful sample evaluation will demonstrate and which observations would require revision. Agree whether the sample is intended to confirm analytical identity, support an assay, assess packaging or inform a larger development project. Different goals may require different quantities and records. A clear evaluation plan makes the quotation and the sample review more useful to both parties.
Commercial and intellectual-property responsibilities should also be visible. Begin with a non-confidential outline if the sequence or process is proprietary, then agree appropriate confidentiality terms before sharing protected information. Confirm that your organization has the right to request the work and define ownership of project-specific deliverables in writing. Changes to the sequence, purification target or packaging should be documented and assessed for their effect on timing and cost. A structured brief reduces avoidable ambiguity; it does not guarantee that every requested synthesis is feasible or accepted.